Chemed Corp. Stock
Price
Target price
€575.00
€575.00
0.880%
5.0
0.880%
€588.14
15.04.24 / Frankfurt
WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chemed Corp. Stock
Chemed Corp. gained 0.880% compared to yesterday.
Our community is currently high on Chemed Corp. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 588 € shows a slightly positive potential of 2.26% compared to the current price of 575.0 € for Chemed Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Chemed Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Chemed Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | 0.880% | -0.870% | -3.390% | 14.000% | 9.615% | 45.408% | 98.918% |
| Amn Healthcare Svs | - | 0.000% | -0.943% | -32.692% | -21.642% | -16.000% | 20.110% |
| Select Medical Holdings | - | -3.650% | 2.326% | 4.762% | 22.222% | -9.589% | 109.557% |
| Neogenomicsinc. | -4.410% | -3.623% | -1.481% | -5.674% | -14.744% | -67.648% | - |
Comments
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $625.00 to $650.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $590.00 to $625.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00